Clinical trial
A Randomized, Multicenter, Masked Evaluation of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate for the Treatment of Inflammation Following Cataract Surgery
NCT01384266 is registered in ClinicalTrials.gov with Associated Eye Care, Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Multicenter, Masked Evaluation of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate for the Treatment of Inflammation Following Cataract Surgery
- Lead sponsor
- Associated Eye Care, Minnesota
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- November 30, 2011
- Enrollment
- 90 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
intraocular inflammation